Pharmacy. Update: Black box warnings for FDA-approved antiretrovirals.
Edmunds-Ogbuokiri
Tina
T
D019380:Anti-HIV Agents / Q000009:adverse effects*; D017277:Drug Approval / Q000331:legislation & jurisprudence*; D004348:Drug Labeling; D017320:HIV Protease Inhibitors / Q000009:adverse effects*; D018894:Reverse Transcriptase Inhibitors / Q000009:adverse effects*; D014481:United States; D014486:United States Food and Drug Administration
D019380:Anti-HIV Agents; D017320:HIV Protease Inhibitors; D018894:Reverse Transcriptase Inhibitors